CoChat
Sign Up
Cited by 38Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Influence of different diagnostic criteria on gestational diabetes mellitus incidence and medical expenditures in China

Open access
He, Zonglin, Xie, Huatao, Liang, Shangqiang, Tang, Yuan, Ding, Wenjing, Wu, Yanxin, Ming, Wai‐kit·2019·Journal of Diabetes Investigation
DOI 10.1111/jdi.13008PMC PMC6717806
Open this paper in CoChat — free accountOpen PDF

Abstract

Aims/Introduction: To summarize the development of the criteria for diagnosing gestational diabetes mellitus (GDM) in China, and investigate how different GDM diagnostic criteria influence the national prevalence of GDM, the national health system and the economic burden of GDM in China. Materials and Methods: Retrospectively using data from women undergoing a 2‐h, 75‐g oral glucose tolerance test at 24–28 gestational weeks in the First Affiliated Hospital of Jinan University (Guangzhou, Guangdong, China) from January 2011 to December 2017, the prevalence rate of GDM and its impacts on the national health system were evaluated using different criteria (the 7th edition textbook criteria, National Diabetes Data Group 1979, World Health Organization 1985, European Association for the Study of Diabetes 1996, Japan 2002, American Diabetes Association [ADA] 2011 [International Association of the Diabetes and Pregnancy Study Groups], and National Institute for Heath and Care Excellence 2015). Results: The incidence rates of GDM based on the ADA 2011 and National Institute for Heath and Care Excellence 2015 were, respectively, 22.94% (P < 0.01) and 21.72% (P < 0.01), over threefold higher than implementing the 7th edition textbook criteria (P < 0.001). On the contrary, the incidence rates of GDM diagnosed with the National Diabetes Data Group 1979 and World Health Organization 1985 guidelines were significantly less than the 7th edition textbook criteria (P < 0.001). From 2001 to 2016, the estimated national cost of treating GDM rose from ¥3.9 billion to ¥27.4 billion after implementing the ADA 2011 guidelines. Conclusions: With the implementation of ADA 2011 (International Association of the Diabetes and Pregnancy Study Groups) guidelines, there are fewer adverse perinatal outcomes and cases of type 2 diabetes mellitus in the long term, but the medical costs increased significantly, and the cost‐effectiveness of diagnostic criteria in China is still yet to be confirmed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jdi.13008

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In China, incidence rates of GDM diagnosed with NDDG1979 and WHO 1985 guidelines were significantly less than the 7th edition textbook criteria.

    “The incidence rates of GDM diagnosed with the NDDG1979 and WHO 1985 guidelines were significantly less than the 7th edition textbook criteria [227].”

    From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [227]

  • In China, He et al. in 2019 evaluated how different GDM diagnostic criteria influenced national prevalence using data from 2011-2017; incidence based on ADA 2011 and NICE were 22.94% and 21.72%, over threefold higher than 7th edition textbook criteria.

    “The incidence of occurrence of GDM based on the ADA 2011 and NICE were 22.94% and 21.72%, over threefold higher than implementing the 7th edition textbook criteria.”

    From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [227]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 27

  1. [1]American Diabetes Association. Summary of revisions to the 2011 clinical practice recommendations. Diabetes Care 2011; 34: S3. 21193626 PMC3006057
  2. [2]Metzger BE, Coustan DR. Summary and recommendations of the fourth international workshop‐conference on gestational diabetes mellitus. The Organizing Committee. Diabetes Care 1998; 21: B161. 9704245
  3. [3]Bellamy L, Casas J‐P, Hingorani AD, et al Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta‐analysis. Lancet 2009; 373: 1773– 1779. 19465232
  4. [5]American Diabetes Association. Position statement. Gestational diabetes mellitus. Diabetes Care 2003; 26: S103– S105. 12502631
  5. [7]Houshmand A, Jensen DM, Mathiesen ER, et al Evolution of diagnostic criteria for gestational diabetes mellitus. Acta Obstet Gynecol Scand 2013; 92: 739– 745. 23600679
  6. [10]Dong Z, Xiao W. The research on the oral glucose tolerance test during the late trimester. Chin J Obstet Gynecol 1993; 3: 136– 138.
  7. [11]Wei Y, Huixia Y. The evolution of the diagnostic criteria for gestational diabetes mellitus. Chinese Journal of Practical Gynecology and Obstetrics. 2013; 4: 295– 298.
  8. [12]Yang H. Obstetrics and Gynecology Branch of Chinese Medical Association. Recommended guidelines for clinical diagnosis and treatment of pregnancy with diabetes (draft). Chinese Journal of Perinatal Medicine. 2007; 23: 475– 477.
  9. [13]Yang H, Xu X, Wang Z et al Obstetrics and Gynecology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of pregnancy complicated with diabetes (2014). Chinese Journal of Obstetrics and Gynecology 2014; 8: 489– 498.
  10. [14]World Health Organization. Diagnostic Criteria and Classification of Hyperglycaemia first Detected in Pregnancy, 2013. 24199271
  11. [15]Yang H. Current status and countermeasures of diagnosis and treatment of gestational diabetes in China. Chin J Pract Gynecol Obstet 2013; 4: 241– 243.
  12. [16]Wei Y, Yang H. Comparison of the diagnostic criteria for gestational diabetes mellitus in China. Chin J Obstet Gynecol 2011; 46: 578– 581. 22169514
  13. [17]Zhu W, Yang H, Wei Y, et al Comparing the diagnostic criteria for gestational diabetes mellitus of World Health Organization 2013 with 1999 in Chinese population. Chin Med J 2015; 128: 125. 25563325 PMC4837807
  14. [19]Miailhe G, Kayem G, Girard G, et al Selective rather than universal screening for gestational diabetes mellitus? Eur J Obstet Gynecol Reprod Biol 2015; 191: 95– 100. 26112365
  15. [20]Jing Z, Ying‐hua X. Age distribution and regional distribution characteristics of 3367 cases of patients with gestational diabetes mellitus. China Modern Med 2016; 23: 156– 159.
  16. [21]National Health and Family Planning Commission. China's Health and Family Planning Statistical Yearbook 2017. Peking Union Medical College Press Beijing, 2017.
  17. [22]Ma X. Treatment and fetal detection of gestational diabetes in rural and remote mountainous areas. The world's latest medical information abstracts 2016; 16: 26– 27.
  18. [23]Wang H, Zhang W. Determinants of Gestational Diabetes Mellitus among Rural Women of Childbearing Age. Chin Mater Child Health Res 2017; 28: 59– 63.
  19. [24]Song G, Yang H. Discussion on diagnostic criteria of gestational diabetes. Chin J Perinat Med 2017; 20: 9.
  20. [30]O'Sullivan JB, Mahan CM. Criteria for the Oral Glucose Tolerance Test in Pregnancy. Diabetes 1964; 13: 278– 285. 14166677
  21. [31]Group NDD. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039– 1057. 510803
  22. [32]Listed N. WHO Expert Committee on Diabetes Mellitus: second report. World Health Organization Technical Report 1980; 646: 1. 6771926
  23. [34]Cunningham F, Leveno K, Bloom S, et al. Overview of obstetrics. Williams obstetrics 23rd ed New York: McGraw‐Hill 2010.
  24. [35]Association AD. Diagnosis and classification of diabetes mellitus. Diabetes care 2004; 27(suppl 1): S5– S10. 14693921
  25. [36]Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med 1998; 15: 539– 553. 9686693
  26. [37]Kawamori R. Diabetes trends in Japan. Diabetes/metabolism Research & Reviews 2002; 18(S3): S9– S13. 12324979
  27. [39]Association AD. Diagnosis and classification of diabetes mellitus. Diabetes care 2014; 37(Supplement 1): S81– S90. 24357215

Cited by

Sorted by citations

Authors
He, Z., Xie, H., Liang, S., Tang, Y., Ding, W., Wu, Y., & Ming, W.
Affiliations
  • Jinan University (CN)
  • The First Affiliated Hospital, Sun Yat-sen University (CN)
  • Harvard University (US)
Corresponding author
Ming, Wai‐kit
ORCID
Venue
Journal of Diabetes Investigation
Publisher
Wiley
Published
2019-02-27
Volume
10
Issue
5
Pages
1347-1357
ISSN
  • 2040-1116 (ISSN-L)
  • 2040-1124
DOI
10.1111/jdi.13008
PMC
PMC6717806
OpenAlex
W2912180825
Cited by
38
References
4
Citations by year
2025: 8 · 2024: 6 · 2023: 2 · 2022: 8 · 2021: 6 · 2020: 6 · 2019: 2
FWCI
5.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Diabetes Investigation (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, diagnostic criteria, GDM prevalence, health care costs, IADPSG criteria, cost-effectiveness, China
MeSH terms
China, Health Expenditures, Female, Follow-Up Studies, Glucose Tolerance Test, Humans, Pregnancy, Pregnancy Outcome, Retrospective Studies, Incidence, Diabetes, Gestational, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review